检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]江西医学院影像系核医学教研室 [2]南昌市第三医院
出 处:《实用癌症杂志》1999年第2期90-92,共3页The Practical Journal of Cancer
摘 要:为探讨血清泌乳素(PRL)与乳腺癌发生、发展的关系。对117例乳腺增生病、36例乳腺纤维腺瘤及51例乳腺癌患者进行了血清PRL含量的测定,对17例乳腺癌及21例纤维腺瘤患者进行了雌激素受体的测定。结果显示:轻度乳腺增生、早期乳腺癌患者血清PRL含量与正常对照组比较无显著性差异(P>0.05),重度乳腺增生、瘤样增生及纤维腺瘤患者均较轻度增生者的血清PRL含量增高(P<0.01);不同期别的乳腺癌患者,其血清PRL含量随期别的增加而显著增高(P<0.01)。提示血清PRL含量增高是促进乳腺癌发展的重要因素。To study the relation between PRL contents and breast cancer,serum PRL and tissue ER contents in patients with hyperplasia fibroadenoma and breast carcinoma at different stages were measured by radioimmunoassay and radioligand binding assay.The results showed that higher PRL levels were found in patients with seriousdegree or liketumor hyperplasia and fibroadenoma compared with lightdegree hyperplasia and normal control group(P<0.05);There were higher ER and lower serum PRL contents in breast cancer than in fibroadenoma(P<0.01);PRL level of patients with breast cancer at different stages increased remarkably with development of the disease(P<0.01).It suggested that PRL increace is a very important factor for the development of breast cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145